KINSELLA: Iraelis' love for Donald Trump fizzles

The article argues that Trump’s standing in Israel has sharply deteriorated as Israeli opinion shifts against his reported Iran deal, which would leave the Iranian regime, IRGC, Strait of Hormuz control, and 1,000 pounds of weapons-grade uranium in place. It frames the agreement as an existential security setback for Israel and a broader geopolitical risk, with potential implications for regional stability and defense-related positioning. The piece also highlights growing frustration in Israel that the U.S. president is no longer seen as a reliable protector.

Analysis

The market implication is not the rhetorical reset around Trump; it is the erosion of U.S. deterrence credibility in the one theater where perception matters most. If allies conclude Washington can be publicly negotiated into accepting a nuclear-capable adversary without extracting verifiable rollback, then the premium shifts from “peace dividend” to “self-help” — more independent defense spending, more indigenous missile defense, and a higher probability of regional proliferation over the next 12-24 months.

That has second-order winners. European and Asian defense primes benefit indirectly because Israel and Gulf partners will increasingly prioritize layered air defense, ISR, EW, and interceptor inventories over legacy platforms. U.S. defense contractors with exposure to munitions, missile defense, and command-and-control should see the cleaner demand signal; the bottleneck is less political budget approval than industrial capacity, which supports multi-quarter order visibility and price power in specific subsegments.

The risk is a short-term complacency trade: if markets interpret diplomacy as de-escalation, near-dated energy and defense vol can compress even as structural risk rises. The real tail event is not immediate conflict but a failure mode where Iran buys time, sanctions leakage continues, and the region enters a more heavily armed equilibrium — which is bearish for airlines, chemical feedstocks, and any cross-border capex dependent on stable Middle East transit.

Contrarianly, the consensus may be underpricing how quickly Israeli strategic behavior can harden if it feels abandoned. That creates asymmetric upside in tactical defense names on any sign of Israeli pre-emption planning, and downside risk to any assets predicated on a durable Middle East détente. The trade is less about the headline and more about the probability distribution shifting toward persistent instability rather than a clean settlement.

Key Decisions for Investors

• Go long LMT / NOC on a 3-6 month horizon; best risk/reward is in missile defense and command-and-control exposure where incremental regional demand can re-rate backlog visibility. Use 5-7% trailing stops if broader defense multiple compression appears.
• Buy ITA call spreads 2-4 months out to express a modestly bullish defense-volatility view with defined risk; prefer strikes around current spot to capture a rerating from any escalation headlines.
• Pair trade long RTX vs short XLE for 6-12 weeks if markets over-rotate toward de-escalation: defense spend should stay sticky while energy can fade on any perceived diplomatic progress, but abandon if Brent breaks higher on shipping disruption risk.
• Avoid or short regional air-transport and leisure proxies with Middle East exposure on any increase in strategic uncertainty; use 1-3 month horizons because booking curves can deteriorate before physical disruption shows up.
• If Israeli policy hardens, add to uranium/security-adjacent names only tactically; keep sizing small because this is a headline-driven trade with high gap risk and no clean catalyst timing.